PMC: PMC Analysis: More Than 20 Percent of FDA's 2014 Novel New Drug Approvals are Personalized Medicines

WASHINGTON, Jan. 28, 2015 /PRNewswire-USNewswire/ -- The Personalized Medicine Coalition (PMC) has concluded its first full assessment of the Novel New Drugs approved by the FDA's Center for Drug Evaluation and Research (CDER) in 2014. The results show that more than 20 percent of the 2014 approvals were personalized medicines.read more